EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
"Living with type 1 diabetes is a constant balancing act for those affected, and the disease still remains insufficiently understood," said Professor
With these research grants, the organizations hope to build upon the goals of the programme to promote and support high quality biomedical and clinical type 1 diabetes research, expedite the practical application of scientific advances and encourage clinical translation of research in
"JDRF is proud to continue its support of this very effective collaboration, which is advancing the highest quality type 1 diabetes research in
"We remain committed to our mission to make the lives of people with diabetes better by advancing cutting-edge research. We are pleased to continue our collaboration with important organizations like EFSD and JDRF to advance that goal," said
For more information on the programme and to apply for 2018 grants, visit http://bit.ly/2GMsnLI.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/newsroom/social-channels. P-LLY
Greg Kueterman; email@example.com; +1(317) 432-5195
Simon Mueller; firstname.lastname@example.org; +49 211 758 469 0; EASD
Kristy Evans; email@example.com; +1(212) 859-7877; JDRF
View original content with multimedia:http://www.prnewswire.com/news-releases/efsd-jdrf-and-lilly-extend-collaboration-supporting-type-1-diabetes-research-300610291.html